Initiatives and programs
We're working on a range of policy initiatives, programs and campaigns to help improve your health and the health of all Australians.
Haemopoietic progenitor cells (HPC) therapy can save the lives of patients with conditions of the blood, blood-producing organs or immune system. The program funds several initiatives to help eligible Australians to access HPC treatments.
The Immunoglobulin Review (Ig Review) Pilot Process is looking at the use of government-funded immunoglobulin treatment for selected conditions. This helps us make sure patients receive the most beneficial treatment available.
The Value in Prescribing (ViP) Program funds resources, tools and interventions. These support specialist health professionals and patients in using immunoglobulin products and alternatives to biological disease-modifying anti-rheumatic drugs (bDMARDs). Read about the program.